TY  - JOUR
AU  - Herrera-Martinez, Aura D
AU  - van den Dungen, Rosanna
AU  - Dogan-Oruc, Fadime
AU  - van Koetsveld, Peter M
AU  - Culler, Michael D
AU  - de Herder, Wouter W
AU  - Luque, Raul M
AU  - Feelders, Richard A
AU  - Hofland, Leo J
PY  - 2019
DO  - 10.1530/ERC-19-0086
UR  - http://hdl.handle.net/10668/13783
T2  - Endocrine-related cancer
AB  - Control of symptoms related to hormonal hypersecretion by functioning neuroendocrine tumors (NETs) is challenging. New therapeutic options are required. Since novel in vitro tumor models seem to better mimic the tumor in vivo conditions, we aimed to...
LA  - en
PB  - BioScientifica
KW  - 3D cell cultures
KW  - hormone secretion
KW  - neuroendocrine tumors
KW  - somatostatin-dopamine chimeric drugs
KW  - Antineoplastic Agents, Hormonal
KW  - Cabergoline
KW  - Cell Culture Techniques
KW  - Cell Proliferation
KW  - Chromogranin A
KW  - Dopamine
KW  - Dopamine Agonists
KW  - Humans
KW  - Neuroendocrine Tumors
KW  - Octreotide
KW  - Receptors, Dopamine
KW  - Receptors, Somatostatin
KW  - Serotonin
KW  - Somatostatin
KW  - Spheroids, Cellular
KW  - Tumor Cells, Cultured
TI  - Effects of novel somatostatin-dopamine chimeric drugs in 2D and 3D cell culture models of neuroendocrine tumors.
TY  - research article
VL  - 26
ER  -